CytomX Therapeutics Inc. (CTMX) slipped -5.14% or -1.68 to $30.89. It is around 164368 shares traded, which is 39.38% compare to the average total volume 417425. The market cap of CTMX is $1.19 billion. The year to date change is 49.63%. The 52 week price range is from $13.0 to $35.0. Price of CTMX have changed -0.61% during last week. It have changed 10.56% over last month, 47.80% over last 3 months, 87.67% over last 6 months and 79.79% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CTMX is 29.26. It is -5.28% below current price. The 200-day Moving Averages for CTMX is 20.82. It is -32.60% below current price. The 52-week High is 35.0. It is 13.31% from the current price. The 52-week Low is 13.0. It is -57.92% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of CTMX is 3.76 on 2018-02-28. Short % to float is 2.89%. There are some statistics of CTMX. It is has market cap $1.19 billion. The share outstanding is 38.61 million. The average volume is 417425. The revenue is 44.55M. The percent of top 15 Institution holding is 54.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CTMX is -54.07%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CTMX is -13.80%.